Beyond Natural Products: Synthetic Analogues of Bryostatin 1

2007 ◽  
pp. 125-162 ◽  
Author(s):  
Paul A. Wender ◽  
Jeremy L. Baryza ◽  
Michael K. Hilinski ◽  
Joshua C. Horan ◽  
Cindy Kan ◽  
...  
2005 ◽  
Vol 2005 (4) ◽  
pp. 254-256 ◽  
Author(s):  
Yong Ye ◽  
Ming-Yu Niu ◽  
Qiang Yin ◽  
Li-feng Cao ◽  
Yu-Fen Zhao

A N-methylpyrrole containing polyamide/peptide conjugates which are synthetic analogues of natural products with DNA affinity was synthesised. It can efficiently hydrolyse PUC19 plasmid DNA. The structure of these compound was confirmed by 1H NMR, MS and IR.


1991 ◽  
Vol 69 (5) ◽  
pp. 856-860 ◽  
Author(s):  
George R. Pettit ◽  
Dipanjan Sengupta ◽  
Cherry L. Herald ◽  
Nancy A. Sharkey ◽  
Peter M. Blumberg

Bryostatin 2 (1a) has been converted to bryostatin 1 (1e) and bryostatin 12 (1i) by a selective protection and deprotection involving the C-26 hydroxyl group. The new bryostatins 1g,1k, and 1m were also prepared starting from bryostatin 2. The C-7 substituents of natural bryostatins 4 and 5 were revised from isovalerate → pivalate employing comparative 1H and 13C NMR studies of the semi-synthetic bryostatins 1k and 1m and the natural products. Key words: bryostatin 2 → 1, selective conversion, bryostatins 4 and 5, pivalates.


Author(s):  
Gaurav Naik ◽  
Ankit Uniyal ◽  
Deepak Chouhan ◽  
Vinod Tiwari ◽  
Alakh Sahu

: Natural products and leads inspired by them have acted as a probe for successful drug discovery for many decades. Pain is an obnoxious sensory and emotional experience associated with potential tissue damage. It affects the quality of life of patients to a great extent. Despite the availability of several agents targeting TRP receptors, none of them can proficiently alleviate neuropathic pain. TRPV1 is a prospective target for treating neuropathic pain as it is recognized to modulate the pain circuitry at the periphery and central level. In this review, we have discussed several natural molecules (such as Capsaicinoids, capsinoids, Piperine, Eugenol, Scutigeral, Ginsenosides, Cinnamaldehyde, Camphor, Shogaol, Gingerols, Zingerone, Allicin, Evodiamine, Allylisothiocyanate, Cannabidiol, Ricinoleic acid, Isovelleral, Capsazepine, Thapsigargin, Pellitorine, Yohimbine, Curcumin) and some semi-synthetic analogues that activate TRPV1 channels, and can be further harnessed consequently for the treatment of neuropathic pain.


Sign in / Sign up

Export Citation Format

Share Document